Close Menu

Affymetrix has received US Patent Number 6,333,155, “Exploiting genomics in the search for new drugs.” The patent covers the use of high-density oligonucleotide probe arrays (read, GeneChips) to monitor changes in mRNA levels in cells treated with drug or therapeutic candidate compounds, in comparison to un-treated cells, in order to determine how the drug affects gene expression and to discover compounds with potentially useful therapeutic affects.

 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.